GALD.SW GALDERMA GROUP N | CH1335392721
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 7.469.000.000 | 6.393.690.420 | 16.82% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 6,64 | 3,64 | 82.44% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 16 | 10 | 60.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |